Apolipoprotein-B-containing lipoproteins and the progression of renal insufficiency

Nephron
O SamuelssonP O Attman

Abstract

Hyperlipidemia is associated with accelerated glomerular sclerosis in experimental renal insufficiency. To investigate whether the dyslipoproteinemia seen in human renal failure also influences the future course of renal insufficiency, we have correlated plasma levels of lipids and apolipoproteins at start of follow-up with the subsequent change in renal function in 34 adult patients with chronic renal disease. Nineteen patients had primary renal disease, and 15 patients had diabetic nephropathy. Except for antihypertensive therapy no specific treatment to modify the progression of the disease was given during the follow-up. The rate of progression was determined by repeated measurements of the glomerular filtration rate (GFR). The time of follow-up ranged from 12 to 91 months with an average of 39.7 +/- 16.7 months. The mean initial GFR was 34.7 +/- 13.9 ml/min x 1.73 m2 body surface area and the average decline in renal function was -0.27 +/- 0.26 ml/min/month. The entry levels of triglycerides (TG; p = 0.04), very-low-density lipoprotein cholesterol (p = 0.03), apolipoprotein-B (ApoB; p = 0.008) and systolic blood pressure (SBP; p = 0.04) were significantly correlated with the rate of progression. Among lipoprotein variables...Continue Reading

Citations

Jan 1, 1997·International Urology and Nephrology·L LöcseyG Balázs
May 1, 1994·Atherosclerosis·E F GröneD Seidel
Jul 21, 1999·Kidney International. Supplement·P O AttmanO Samuelsson
Jul 21, 1999·Kidney International. Supplement·S YukawaY Tone
Jun 6, 2003·Kidney International·Barry M Brenner
May 30, 1998·Journal of Cardiovascular Pharmacology·K Makrilakis, G Bakris
Jul 18, 2001·Current Opinion in Nephrology and Hypertension·M W Taal, B M Brenner
Jan 30, 2010·Journal of Lipid Research·Deepa TanejaLisa R Tannock
Sep 15, 1995·Journal of Chromatography. B, Biomedical Applications·T Tadey, W C Purdy
Jun 1, 1993·American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation·P O AttmanP Alaupovic
Oct 2, 2004·Kidney International·Anja S MühlfeldCharles E Alpers
Sep 1, 1994·Kidney International·W F Keane
Feb 1, 1994·Kidney International·E RitzJ Wagner
Sep 23, 2008·Life Sciences·Vaijinath S KamannaShobha H Ganji
Apr 26, 2008·American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation·Janice LeaUNKNOWN AASK Study Investigators
Dec 1, 2001·American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation·M W Taal, B M Brenner
Mar 4, 2003·American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation·Stefano BianchiVito M Campese
Apr 28, 2004·Clinical Therapeutics·Sarkis B BaghdasarianByron J Hoogwerf
Aug 9, 2005·Cardiology Clinics·William F Keane, Paulette A Lyle
Jun 15, 2005·Diabetes Research and Clinical Practice·Lawrence A Leiter
Jul 13, 1995·The American Journal of Cardiology·C J LintottB I Shand
Jul 15, 2000·Clinical Nutrition : Official Journal of the European Society of Parenteral and Enteral Nutrition·G ToigoC Wanner
May 21, 2013·Clinical Journal of the American Society of Nephrology : CJASN·Janice P Lea
Feb 27, 2015·Journal of Complementary & Integrative Medicine·Subhadip BanerjeePratip K Debnath
Oct 21, 1999·Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association·Z A MassyP Jungers
Apr 28, 2004·Clinical Transplantation·Mario SénéchalIradj Gandjbakhch
Dec 23, 1999·Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association·J SyrjänenA Pasternack
May 9, 1998·Renal Failure·P CappelliA Albertazzi

❮ Previous
Next ❯

Related Concepts

Related Feeds

Antihypertensive Agents: Mechanisms of Action

Antihypertensive drugs are used to treat hypertension (high blood pressure) which aims to prevent the complications of high blood pressure, such as stroke and myocardial infarction. Discover the latest research on antihypertensive drugs and their mechanism of action here.

ApoE, Lipids & Cholesterol

Serum cholesterol, triglycerides, apolipoprotein B (APOB)-containing lipoproteins (very low-density lipoprotein (VLDL), immediate-density lipoprotein (IDL), and low-density lipoprotein (LDL), lipoprotein A (LPA)) and the total cholesterol/high-density lipoprotein (HDL) cholesterol ratio are all connected in diseases. Here is the latest research.

Related Papers

Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association
V HugueC Cachera
Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association
O SamuelssonP Alaupovic
© 2021 Meta ULC. All rights reserved